<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Robertson MJ</submitter><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>124-135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8760134</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>47(2)</volume><pubmed_abstract>Structure-based drug discovery (SBDD) is an indispensable approach for the design and optimization of new therapeutic agents. Here, we highlight the rapid progress that has turned cryo-electron microscopy (cryoEM) into an exceptional SBDD tool, and the wealth of new structural information it is providing for high-value pharmacological targets. We review key advantages of a technique that directly images vitrified biomolecules without the need for crystallization; both in terms of a broader array of systems that can be studied and the different forms of information it can provide, including heterogeneity and dynamics. We discuss near- and far-future developments, working in concert towards achieving the resolution and throughput necessary for cryoEM to make a widespread impact on the SBDD pipeline.</pubmed_abstract><journal>Trends in biochemical sciences</journal><pubmed_title>Drug discovery in the era of cryo-electron microscopy.</pubmed_title><pmcid>PMC8760134</pmcid><funding_grant_id>R01 NS092695</funding_grant_id><funding_grant_id>R01 NS122394</funding_grant_id><funding_grant_id>T32 GM089626</funding_grant_id><pubmed_authors>Skiniotis G</pubmed_authors><pubmed_authors>Meyerowitz JG</pubmed_authors><pubmed_authors>Robertson MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Drug discovery in the era of cryo-electron microscopy.</name><description>Structure-based drug discovery (SBDD) is an indispensable approach for the design and optimization of new therapeutic agents. Here, we highlight the rapid progress that has turned cryo-electron microscopy (cryoEM) into an exceptional SBDD tool, and the wealth of new structural information it is providing for high-value pharmacological targets. We review key advantages of a technique that directly images vitrified biomolecules without the need for crystallization; both in terms of a broader array of systems that can be studied and the different forms of information it can provide, including heterogeneity and dynamics. We discuss near- and far-future developments, working in concert towards achieving the resolution and throughput necessary for cryoEM to make a widespread impact on the SBDD pipeline.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-19T14:19:46.417Z</modification><creation>2025-02-19T04:45:58.078Z</creation></dates><accession>S-EPMC8760134</accession><cross_references><pubmed>34281791</pubmed><doi>10.1016/j.tibs.2021.06.008</doi></cross_references></HashMap>